Im, Y. Et Al. 2021. Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES. BREAST CANCER RESEARCH AND TREATMENT , vol.188, no.1 , 77-89.

Im, Y., KARABULUT, B., Lee, K. S., Park, B., Adhav, A., Cinkir, H. Y., ... Abdel-Razeq, H.(2021). Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES. BREAST CANCER RESEARCH AND TREATMENT , vol.188, no.1, 77-89.

Im, Young-Hyuck Et Al. "Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES," BREAST CANCER RESEARCH AND TREATMENT , vol.188, no.1, 77-89, 2021

Im, Young-Hyuck Et Al. "Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES." BREAST CANCER RESEARCH AND TREATMENT , vol.188, no.1, pp.77-89, 2021

Im, Y. Et Al. (2021) . "Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES." BREAST CANCER RESEARCH AND TREATMENT , vol.188, no.1, pp.77-89.

@article{article, author={Young-Hyuck Im Et Al. }, title={Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES}, journal={BREAST CANCER RESEARCH AND TREATMENT}, year=2021, pages={77-89} }